Relmada Therapeutics
RLMD
RLMD
93 hedge funds and large institutions have $66.5M invested in Relmada Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 9 closing their positions.
Holders
93
Holders Change
+10
Holders Change %
+12.05%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
21
Reduced
26
Closed
9
Calls
$907K
Puts
$602K
Net Calls
+$305K
Net Calls Change
+$1.42M
Top Buyers
| 1 |
VPC
1
Vestal Point Capital
New York
|
$5.58M |
| 2 |
2
Franklin Resources
San Mateo,
California
|
$2.93M |
| 3 |
3
Jane Street
New York
|
$815K |
| 4 |
4
JPMorgan Chase & Co
New York
|
$818K |
| 5 |
5
Millennium Management
New York
|
$1.59M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | – | -74 | Closed |
|
102
Russell Investments Group
London,
United Kingdom
| – | – | -53 | Closed |
|
|
CFGS
103
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|